Ping Cao
Principal investigator.
Biotech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2019First federal award
$467KFederal grants as PI2 awards
2Patents grantedLatest Sep 9, 2025
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
2 awards · $467K
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Sep 18, 2020 | NIH | STTR Phase I Development of an irreversible covalent inhibitor of FMS-like tyrosine kinase receptor 3 for treating acute myeloid leukemia | $299K | BRIDGENE BIOSCIENCES, INC. |
| Mar 13, 2019 | NIH | SBIR Phase I A Novel Chemical Proteomics Platform to Expand Druggable Space | $168K | BRIDGENE BIOSCIENCES, INC. |
3 patents as inventor
- US 12392778BRIDGENE BIOSCIENCES, INC.Aug 19, 2025
- US 12409177BRIDGENE BIOSCIENCES, INC.Sep 9, 2025
- US BRIDGENE BIOSCIENCES, INC.—
Matched by the first inventor’s name and the patent’s company.
Peer ranks
Federal funding#2,473
Awards as PI#1,252
Patents#102
Companies
- BRIDGENE BIOSCIENCES, INC.Linked by awards · Biotech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.